Global stockmarkets notched up record gains in November
Global stockmarkets have enjoyed their best month since 1988 this November, with the MSCI World index up 12.6%.

Global stocks have enjoyed their best month since 1988. The MSCI World index gained 12.6% in November, says David Randall on Reuters. Around $6.7trn was added to the value of global shares, equivalent to “$155m a minute”.
The pan-European Stoxx 600 enjoyed its best ever month, gaining 13.7% as the French and Italian markets notched up record returns. The FTSE 100 also had a record month (see page 5). The 15% gain on Japan’s Nikkei index was its best showing since 1994.
A month that started with Joe Biden’s election victory and progressed with a positive stream of vaccine updates kept investors in good spirits, say Claire Ballentine and Katherine Greifeld on Bloomberg. America’s S&P 500 gained 11%, a rare instance of it lagging the global average. The key theme of the month was rotation as investors moved out of tech shares and began to buy a broader range of smaller and more cyclical stocks. The tech giants lagged small caps. That goes to show that the market is finally “widening”, says Karen Langley in The Wall Street Journal. This year’s rally has been heavily concentrated in a handful of sectors. In September only 153 of the 500 shares in the S&P 500 made gains; in November, 467 did. A 17% jump in US financial shares gave the sub-index its “best month since April 2009”.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE

Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Another boost came from positive earnings news. Average S&P 500 third-quarter earnings came in only 6% lower than last year, defying predictions of a 21% slump. It is extraordinary that global markets have gained this year, even as “the virus is still on the rampage”, says Rupert Thompson of Kingswood. In a year where massive central bank support has juiced markets, rarely has the old saying, “don’t fight the Fed”, been so true.
Sign up for MoneyWeek's newsletters
Get the latest financial news, insights and expert analysis from our award-winning MoneyWeek team, to help you understand what really matters when it comes to your finances.
Alex is an investment writer who has been contributing to MoneyWeek since 2015. He has been the magazine’s markets editor since 2019.
Alex has a passion for demystifying the often arcane world of finance for a general readership. While financial media tends to focus compulsively on the latest trend, the best opportunities can lie forgotten elsewhere.
He is especially interested in European equities – where his fluent French helps him to cover the continent’s largest bourse – and emerging markets, where his experience living in Beijing, and conversational Chinese, prove useful.
Hailing from Leeds, he studied Philosophy, Politics and Economics at the University of Oxford. He also holds a Master of Public Health from the University of Manchester.
-
8 of the best houses for sale with annexes
The best houses with annexes – from a period property in the Lake District to a 13th-century house with a two-bedroom annexe in Saltwood, Kent
By Natasha Langan Published
-
Zelenskyy moves to appease Donald Trump – what happens now?
Ukraine’s president Volodymyr Zelenskyy is conceding ground to secure the least-worst deal possible, says Emily Hohler
By Emily Hohler Published
-
Rolls-Royce stock jumps 15% – could it climb further?
Aircraft-engine group Rolls-Royce’s CEO has been hailed as a hero for spearheading the firm’s recovery. And the future looks bright, says Matthew Partridge
By Dr Matthew Partridge Published
-
The power of private markets
Interview Helen Steers, co-manager of the Pantheon International investment trust, tells MoneyWeek about the vast array of compelling opportunities in private equity
By Andrew Van Sickle Published
-
Vertex Pharmaceuticals is an uncommon opportunity in rare diseases
Vertex Pharmaceuticals operates in a profitable subsector and is poised for further success
By Dr Mike Tubbs Published
-
Global investors have overlooked these top tips in emerging markets
Opinion Chris Tennant, co-portfolio manager of Fidelity Emerging Markets, picks three attractive companies in emerging markets
By Chris Tennant Published
-
King Coal has not been dethroned yet — should you buy?
The demand for coal is only growing, yet investors don’t seem to want to take advantage of the opportunity, says Rupert Hargreaves
By Rupert Hargreaves Published
-
It’s time to start buying Europe again, says Merryn Somerset Webb
Opinion Europe's stocks are cheap and the economic backdrop is starting to look cheerier, says Merryn Somerset Webb
By Merryn Somerset Webb Published
-
Prosus to buy Just Eat for €4.1 billion as takeaway boom fades
Food-delivery platform Just Eat has been gobbled up by a Dutch rival. Now there could be further consolidation in the sector
By Dr Matthew Partridge Published
-
Should investors stay bullish and buy UK and US stocks?
Opinion Ignore the Eeyores, says Max King. The outlook for stocks in both Britain and America remains auspicious
By Max King Published